It'll start paying dividends when the FTC witchhunt is over!!!!
The amount of management time and legal / consultant / auditor fees they've spent on this entire Ackman/FTC witchhunt is worth at least $0.5-$1.0 EPS which would likely be given back to shareholders once this issue is finally resolved.
Come on FTC issue your findings and let's get on with business. Ackman has had way to much power over this stock, it's criminal to allow him to trash this company w/o any really facts, just opinions!!!
Just thought I'd through in that South Park reference...since we're already starting to see all the 'TIMMMBBER' posts!!! Good luck longs.....shorts can burn in hell!!!
This sort of #$%$ by analysts should be illegal....they hide behind the name of 'Citi' or whatever large bank they work for.....they can basically write anything they want without any risk of prosecution. Their 'analysis' usually has significant impact on shares, access to capital, customer confidence, etc etc....in most cases there is little or no data to back their 'analysis', but just like screaming fire in a theater...they cause significant damage by giving their irresponsible opinion which is disguised as 'analysis'. I question whether these analysts release their reports, just after someone within their own organization has taken a short position in the particular stock. This is just my opinion...but it's based on a pattern I've noticed over a number of years.
Natural profit taking today.....
This thing is not slowing down....will get lots of M&A interest for a large biotech....they would gladly pay $500 million if this drug has even a small promise.......FDA approval would be worth Billions!!!!
Based on the strength of the day and continued upward movement....it's a given this will be at $20 by close tomorrow....
This is not based some crazy analysis....it's based on momentum and short squeeze. This could go way higher...30s or 40s if there are any rumors of a buy out. The market cap of this company is pocket change for most pharmas/biotech....they will pay $500 million in a heart beat if they believe there is promise of this drug.
If this drug ever receives FDA approval.......we're talking about a multiple billion market cap...so $30 or $40 per share is just based on some potential this drug might work out....
Save this post....with a market cap of less than $200M.....this is peanuts to most large pharm. companies which will drive this company to over $1B market cap in a few months. This therapy works....a large pharma will buy just to get their hands on this new therapy and new revenue source.
Sentiment: Strong Buy
My advise is to get away from this stock ASAP!!! Management clearly is trying to sell all their shares before they release all the negative information. Clear manipulation / management of news releases to ensure stock was going higher and then most likely sold before news was released by the FDA.
Why didn't they release the cancellation of the clinical trials at the same time as the FDA release??? Answer: They needed a few more days to finish off-loading the rest of their stock.
I hope the lawyers have a field day with these guys!!!!
Next stop BK!!!!!!!!!!!!!
Sentiment: Strong Sell
Don't get me wrong...this company has some serious problems they need to address w/ this drug, but it's WAY oversold.
It'll be a slow climb back up with some bumps on the road....too many mutual funds have money invested here, they'll do anything to see this climb back up before they jump all together.
Save this post!!!
Sentiment: Strong Buy
Ackman....I'm not going to charge you for that incredibly hard piece of advise!!!!!
#$%$ yeah!!!!!! By the end of the week!!!!
Not because it's a great company, but because of all the shorts will have to cover!!!!!!
Besides even at $20, this thing is not even worth $1B.....Wall Street spends more on #$%$ per year than this company's market cap!!!!